Welcome to fibrogenesis & tissue ... [Fibrogenesis Tissue Repair. 2008] - PubMed

Hepatic wound repair. [Fibrogenesis Tissue Repair. 2009]
Hepatic wound repair.
Parola M, Pinzani M. Fibrogenesis Tissue Repair. 2009 Sep 25; 2(1):4. Epub 2009 Sep 25.
Redox mechanisms in hepatic chronic wound healing and fibrogenesis. [Fibrogenesis Tissue Repair. 2008]
Redox mechanisms in hepatic chronic wound healing and fibrogenesis.
Novo E, Parola M. Fibrogenesis Tissue Repair. 2008 Oct 13; 1(1):5. Epub 2008 Oct 13.
The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis. [Hepatology. 2009]
The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis.
Weng HL, Liu Y, Chen JL, Huang T, Xu LJ, Godoy P, Hu JH, Zhou C, Stickel F, Marx A, et al. Hepatology. 2009 Jul; 50(1):230-43.
Review Endothelin receptor selectivity: evidence from in vitro and pre-clinical models of scleroderma. [Eur J Clin Invest. 2009]
Review Endothelin receptor selectivity: evidence from in vitro and pre-clinical models of scleroderma.
Shiwen X, Leask A, Abraham DJ, Fonseca C. Eur J Clin Invest. 2009 Jun; 39 Suppl 2:19-26.
Review Interrelation of immunity and tissue repair or regeneration. [Semin Cell Dev Biol. 2009]
Review Interrelation of immunity and tissue repair or regeneration.
Eming SA, Hammerschmidt M, Krieg T, Roers A. Semin Cell Dev Biol. 2009 Jul; 20(5):517-27. Epub 2009 Apr 22.

CCN2: a bona fide target for anti-fibrotic drug intervention. [J Cell Commun Signal. 2011]
CCN2: a bona fide target for anti-fibrotic drug intervention.
Leask A. J Cell Commun Signal. 2011 Jun; 5(2):131-3. Epub 2011 Mar 6.
Mesenchymal stem cell therapy: Two steps forward, one step back. [Trends Mol Med. 2010]
Mesenchymal stem cell therapy: Two steps forward, one step back.
Ankrum J, Karp JM. Trends Mol Med. 2010 May; 16(5):203-9. Epub 2010 Mar 23.
Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease? [J Cell Commun Signal. 2009]
Connective tissue growth factor (CTGF, CCN2) gene regulation: a potent clinical bio-marker of fibroproliferative disease?
Leask A, Parapuram SK, Shi-Wen X, Abraham DJ. J Cell Commun Signal. 2009 Jun; 3(2):89-94. Epub 2009 Jan 21.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Free in PMC
Free full text articles in PMC
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Welcome to fibrogenesis & tissue repair.
Welcome to fibrogenesis & tissue repair.
Fibrogenesis Tissue Repair. 2008 Oct 13 ;1(1):1.

PubMed
Achievements and challenges in bioartificial kidney development.
Achievements and challenges in bioartificial kidney development.
Fibrogenesis Tissue Repair. 2010 Aug 10 ;3:14.

PubMed
Serum amyloid P ameliorates radiation-induced oral mucositis and fibrosis.
Serum amyloid P ameliorates radiation-induced oral mucositis and fibrosis.
Fibrogenesis Tissue Repair. 2010 Jul 5 ;3:11.

PubMed
Mesenchymal cell survival in airway and interstitial pulmonary fibrosis.
Mesenchymal cell survival in airway and interstitial pulmonary fibrosis.
Fibrogenesis Tissue Repair. 2010 Aug 25 ;3:15.

PubMed
Angiogenesis and chronic kidney disease.
Angiogenesis and chronic kidney disease.
Fibrogenesis Tissue Repair. 2010 Aug 5 ;3:13.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed